PRF1 and neoplasm: Moreover, we observed proliferation of T cells featuring Ki67 expression and enhanced anti‐tumor immunity featuring perforin and IFNG upregulation within the TIME after ICB treatment, especially in the anti‐TIGIT group (Figure 5H).